600829.SH
HPGC Renmintongtai Pharmaceutical Corp.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.22
−4.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 39.95x
- PEG TTM
- —
- Price / book
- 1.73x
- Price / sales
- 0.53x
- Price / cash flow
- 21.16x
Enterprise value
- Enterprise value
- CNY 5.4B
- EV / sales
- 0.51x
- EV / EBITDA
- 24.68x
- EV / EBIT
- 26.76x
- Market cap
- CNY 5.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026